Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
20% Albumin infusion and AKI following cardiac surgery – Randomised Trial
2022-003000-32Phase 4Completed
- Sponsor
- Monash University
- Start
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of albumin (human) in acute kidney failure (AKF) (2 arms), sponsored by Monash University. Primary endpoints: Incidence of AKI (stage I, II and III) and In-hospital AKI stage II and III. Started Jan 2023; status: completed.
02
Drugs
albumin (human)
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2022-003000-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003000-32.